Le T, Le C, Nguyen T
Nat Commun. 2024; 15(1):8989.
PMID: 39420173
PMC: 11487123.
DOI: 10.1038/s41467-024-53322-1.
Lane A, Higashi R, W-M Fan T
Metabolites. 2024; 14(7).
PMID: 39057706
PMC: 11278851.
DOI: 10.3390/metabo14070383.
Traber G, Yu A
Mol Pharmacol. 2024; 106(1):13-20.
PMID: 38719476
PMC: 11187687.
DOI: 10.1124/molpharm.124.000895.
Montagud-Martinez R, Marquez-Costa R, Heras-Hernandez M, Dolcemascolo R, Rodrigo G
Microb Biotechnol. 2024; 17(2):e14418.
PMID: 38381083
PMC: 10880580.
DOI: 10.1111/1751-7915.14418.
Ishikawa T, Sugawara K, Zhang J, Funatsu T, Okabe K
iScience. 2024; 27(2):108811.
PMID: 38303695
PMC: 10831896.
DOI: 10.1016/j.isci.2024.108811.
Two-motif model illuminates DICER cleavage preferences.
Le C, Nguyen T, Nguyen T
Nucleic Acids Res. 2024; 52(4):1860-1877.
PMID: 38167721
PMC: 10899750.
DOI: 10.1093/nar/gkad1186.
A signal recognition particle receptor gene from the sea cucumber, Apostichopus japonicas.
Zhang J, Sun Z, Su W, Wang Z, Meng W, Chang Y
Sci Rep. 2023; 13(1):22973.
PMID: 38151522
PMC: 10752883.
DOI: 10.1038/s41598-023-50320-z.
Mfap4: a promising target for enhanced liver regeneration and chronic liver disease treatment.
Iakovleva V, Wuestefeld A, Ong A, Gao R, Kaya N, Lee M
NPJ Regen Med. 2023; 8(1):63.
PMID: 37935709
PMC: 10630300.
DOI: 10.1038/s41536-023-00337-9.
The emerging roles of long noncoding RNAs in lymphatic vascular development and disease.
Ivanov K, Samuilova O, Zamyatnin Jr A
Cell Mol Life Sci. 2023; 80(8):197.
PMID: 37407839
PMC: 10322780.
DOI: 10.1007/s00018-023-04842-4.
Terminal bridging of siRNA duplex at the ribose 2' position controls strand bias and target sequence preference.
Shibata A, Shirohzu H, Iwakami Y, Abe T, Emura C, Aoki E
Mol Ther Nucleic Acids. 2023; 32:468-477.
PMID: 37168798
PMC: 10165404.
DOI: 10.1016/j.omtn.2023.04.013.
MicroRNAs: master regulators in host-parasitic protist interactions.
Rojas-Pirela M, Andrade-Alviarez D, Medina L, Castillo C, Liempi A, Guerrero-Munoz J
Open Biol. 2022; 12(6):210395.
PMID: 35702995
PMC: 9198802.
DOI: 10.1098/rsob.210395.
Secondary structure RNA elements control the cleavage activity of DICER.
Nguyen T, Trinh T, Bao S, Nguyen T
Nat Commun. 2022; 13(1):2138.
PMID: 35440644
PMC: 9018771.
DOI: 10.1038/s41467-022-29822-3.
-targeting miR-agshRNAs combine efficacy with specificity and safety for retinal gene therapy.
Alsing S, Doktor T, Askou A, Jensen E, Ahmadov U, Kristensen L
Mol Ther Nucleic Acids. 2022; 28:58-76.
PMID: 35356684
PMC: 8933642.
DOI: 10.1016/j.omtn.2022.02.019.
Triggering RNAi with multifunctional RNA nanoparticles and their delivery.
Dao B, Viard M, Martins A, Kasprzak W, Shapiro B, Afonin K
DNA RNA Nanotechnol. 2021; 2(1):1-12.
PMID: 34322586
PMC: 8315566.
DOI: 10.1515/rnan-2015-0001.
Computational insights into RNAi-based therapeutics for foot and mouth disease of Bos taurus.
Sahu T, Gurjar A, Meher P, Varghese C, Marwaha S, Rao G
Sci Rep. 2020; 10(1):21593.
PMID: 33299096
PMC: 7725835.
DOI: 10.1038/s41598-020-78541-6.
Design, mechanism, delivery and therapeutics of canonical and Dicer-substrate siRNA.
Abdul Ghafoor Raja M, Katas H, Amjad M
Asian J Pharm Sci. 2020; 14(5):497-510.
PMID: 32104477
PMC: 7032099.
DOI: 10.1016/j.ajps.2018.12.005.
Editorial focus: understanding off-target effects as the key to successful RNAi therapy.
Bartoszewski R, Sikorski A
Cell Mol Biol Lett. 2019; 24:69.
PMID: 31867046
PMC: 6902517.
DOI: 10.1186/s11658-019-0196-3.
Antiviral RNAi in Insects and Mammals: Parallels and Differences.
Schuster S, Miesen P, van Rij R
Viruses. 2019; 11(5).
PMID: 31100912
PMC: 6563508.
DOI: 10.3390/v11050448.
Influence of a 3' Terminal Ribozyme on AgoshRNA Biogenesis and Activity.
Herrera-Carrillo E, Gao Z, Berkhout B
Mol Ther Nucleic Acids. 2019; 16:452-462.
PMID: 31048184
PMC: 6488825.
DOI: 10.1016/j.omtn.2019.04.001.
Enhancement of gene knockdown efficiency by CNNC motifs in the intronic shRNA precursor.
Park S, Kee Y, Hwang B
Genes Genomics. 2019; 41(4):491-498.
PMID: 30656519
DOI: 10.1007/s13258-019-00783-0.